Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
33
-
Total shares
-
1.1M
-
Shares change
-
+783K
-
Total reported value, excl. options
-
$1.27M
-
Value change
-
+$901K
-
Number of buys
-
26
-
Number of sells
-
-5
-
Price
-
$1.15
Significant Holders of Calidi Biotherapeutics, Inc. - COM NEW (CLDI) as of Q4 2024
37 filings reported holding CLDI - Calidi Biotherapeutics, Inc. - COM NEW as of Q4 2024.
Calidi Biotherapeutics, Inc. - COM NEW (CLDI) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.1M shares
.
Largest 10 shareholders include GEODE CAPITAL MANAGEMENT, LLC (160K shares), MILLENNIUM MANAGEMENT LLC (136K shares), HighTower Advisors, LLC (102K shares), CPR Investments Inc. (101K shares), DRIVE WEALTH MANAGEMENT, LLC (90K shares), Red Wave Investments LLC (80.8K shares), Virtu Financial LLC (73.4K shares), VANGUARD GROUP INC (61.4K shares), RS CRUM INC. (40.5K shares), and JANE STREET GROUP, LLC (33.4K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.